The Quantellect read.As of Nov 19, 2026, 3 active firms cover Minerva Neurosciences Inc: 2 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets range widely, $7.00 to $14.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $10.33 sits 372% above the current $2.19. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.09 next quarter toward $-0.42 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy267%
Neutral133%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$10.33
+371.8% upside
Average target across 3 active firms as of Nov 19, 2026 vs $2.19 current
Highest Target$14.00
Average Target$10.33
Lowest Target$7.00
Detailed analyst forecasts for NERV
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 2 of 3 active firms rate NERV a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
NERV EPS & revenue forecast
EPS · NEXT QUARTER
$-0.09
Range $-0.09 – $-0.09 · 1 analysts · -47% YoY
Next period, 1 analysts expect Minerva Neurosciences Inc to earn $-0.09 a share (range $-0.09 – $-0.09), versus $-0.17 a year earlier. Full-year consensus is $-0.54, growing to $-0.42 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Minerva Neurosciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NERV.
#1
Jason Butler
JMP Securities · Rank #62
Buy
$14.00+539.3% to target
Overall win rate
49%
+ Follow
#2
Douglas Tsao
HC Wainwright & Co. · Rank #312
Neutral
$7.00+219.6% to target
Overall win rate
35%
+ Follow
#3
Andrew Tsai
Jefferies
Buy
$10.00+356.6% to target
Coverage
—
+ Follow
#4
BA
Biren Amin
Jefferies
Buy
$10.00+356.6% to target
Coverage
—
+ Follow
#5
JN
Jason N. Butler
Citizens
Buy
$14.00+539.3% to target
Coverage
—
+ Follow
NERV stock forecast FAQ
What is NERV's average 12-month price target?+
The 3 active firms with a live target average $10.33 for Minerva Neurosciences Inc over the next 12 months, ranging from a $14.00 high to a $7.00 low, as of Nov 19, 2026.
Is NERV stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for NERV?+
The Street-high target is $14.00 (Citizens), and the Street-low is $7.00 (HC Wainwright & Co.). The average of all 3 active-firm targets is $10.33.
How many active Wall Street firms cover NERV?+
3 active firms have a recognized rating on Minerva Neurosciences Inc as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering NERV?+
Among analysts who currently cover NERV, Jason Butler of JMP Securities has the strongest overall Quantellect track record (Rank #62). Their current call is Buy with a $14.00 target.
What is Minerva Neurosciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.09 per share (range $-0.09 – $-0.09) across 1 analysts. Full-year EPS is projected at $-0.54, rising to $-0.42 the following year.
How much revenue is Minerva Neurosciences Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading NERV lately?+
As of Nov 19, 2026, 2 of 3 active firms rate NERV a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NERV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.